RT @MPishvaian
@hopkinskimmel #HopkinsGI
If you choose neo (or peri) adjuvant chemotherapy, what would be your preferred regimen:

RT @MPishvaian
@hopkinskimmel #HopkinsGI
Would love to hear your voices - let's take a poll:

For a patient with CLEARLY RESECTABLE, but high risk intrahepatic cholangiocarcinoma would you recommend:

RT @MPishvaian
@hopkinskimmel #HopkinsGI
🤔What are your💭on this debate - would you prefer to give neoadjuvant (or peri-adjuvant) chemotherapy
OR
only adjuvant chemotherapy for a resectable intrahepatic #cholangiocarcinoma
➡️@MarkYarchoan and Tom Karasic (from UPENN) are debating🗣️this now

RT @MPishvaian
@hopkinskimmel #HopkinsGI
But @VivekSubbiah 🗣️also challenged us to change the WAY we think about💊development
👉Change the WAY we test🎯💊
👉Change the WAY drugs get approved
👉And change the WAY we test patients🧬to determine if these therapies will work for them

RT @timpawlik
Great to see my @HopkinsMedicine friends! Appreciate the invite to talk on controversies in #surgery / locoregional treatment of #NeuroendocrineCancer at @hopkinskimmel #HopkinsGI Updates Course. Wonderful course featuring #patients and #expert #cancer providers!

RT @VivekSubbiah
⚡️🚨Looking forward to deliver the keynote address on #precisionmedicine in GI cancers at Johns Hopkins Updates in GI Cancers @hopkinskimmel #HopkinsGI @MPishvaian
👉Fantastic agenda & amasing speaker line up @OncoAlert @TumorBoardTues

https://integrityce.com/hopkins-gi-agenda/ https://twitter.com/MPishvaian/status/1621863389508026371

RT @MPishvaian
@hopkinskimmel #HopkinsGI
🏁Kicking things off with @marshalj23 & his wife, Liza🗣️their experiences as a patient & caregiver - sharing the stories from their📕"Off Our Chests"

🙏for being so open & candid. You motivate encourage patients, caregivers, and health care providers‼️